ALERT CONTENT PLACEHOLDER

Welcome

WINNERS of the ISACHD AWARDS

​ISACHD YOUNG INVESTIGATOR RESEARCH AWARD

FEASIBILITY AND EFFICACY OF NEGATIVE PRESSURE VENTILATION IN THE AMBULATORY FONTAN POPULATION – (FONTAN-CMR) – A PILOT STUDY

Pradeepkumar Charla; Shi Joon Yoo; Gauri Rani Kaur; Kenichiro Yamamura; John T Granton; Erwin Oechslin; Ashish Shah; Eric Horlick; Lee Benson; Osami Honjo; Rachel M Wald
Toronto Congenital Cardiac Center for Adults, Toronto General Hospital, Peter Munk Cardiac Center, University of Toronto, Toronto, Canada

ISACHD CARDIAC CARE ASSOCIATE INVESTIGATOR AWARD

HEALTH LITERACY IN ADULTS WITH CONGENITAL HEART DISEASE

Susan Fernandes; Christy Sillman; Tara Dade; Emily Dong; Christiane Haeffele; George Lui; Ian Rogers; Anitra Romfh; Caroline Scribner; Lee Sanders
Stanford University School of Medicine, Stanford, California, USA

All accepted abstracts are available under Abstract Presentations​.

​​​On behalf of the Organizing Committee, I would like to invite you to participate in the 28th Annual International Symposium on Adult Congenital Heart Disease. This Symposium reflects a long partnership between the faculties of Oregon Health & Science University, Cincinnati Children's Hospital Medical Centre/University of Cincinnati and University of Toronto. It is a unique forum where medical professionals meet their colleagues from around the world, and exchange ideas and information in the rapidly growing field of Adult Congenital Heart Disease.

International faculty and attendees have gathered annually to educate, learn and receive updates of the latest innovations in diagnosis and management for Adult Congenital Heart Disease.

Tackling & Transforming Outcomes of Complex ACHD is the theme of this year's Symposium. Number and complexity of ACHD patients are rapidly increasing, and the medical community is facing new challenges in this unique population.

Congenital heart disease is a lifespan disease​, with different aspect during the journey of our patients, and this aspect – from infancy to adulthood – will be featured in some sessions.

We will cover lesion-specific complications and challenges regarding management, but we will also address tough end of life questions, frequently addressed to late or even neglected.

Toronto, with its very long and strong history in congenital heart disease (CHD), is the home of thousands of pediatric and adult CHD patients. It has built on its tradition and legacy on excellence in patient care, education and research. The Toronto faculty will report about the Toronto experiences and lessons learnt from patients with heart failure, and with transposition of the great arteries, with a special focus as a lifespan disease.

This year's Symposium presents new and special features:

  • The Inaugural Dr. Gary Webb Lecture, introduced to honou​r his great contributions to the field ACHD, with global impact will be given by Dr. Gary Webb.
  • MED Talks, first presented at the Cincinnati meeting 2017, is modelled on the TED talks and are devoted to spreading ideas in the form of short and powerful talks from expert speakers.
  • Breakout sessions tailored to meet the educational needs of the ACHD trainees/fellows and of the non-physicians
  • Investigators will present oral abstracts related to the topic discussed in the plenary sessions.
  • Hands-on Specimens from 3-D Printing introduce a new era of education and allow participants to study anatomy of complex congenital heart defects.
  • The International Society of Adult Congenital Heart Disease (ISACHD) will award the best abstracts submitted by Physicians and by Cardiac Care Associates. The winners will receive the ISACHD Young Investigator Award and the ISACHD Cardiac Care Associate Investigator Award.​

The following topics amongst others will be discussed:

  • Toronto experiences from the Toronto ACHD Heart Failure Clinic
  • Transposition of the great arteries – Toronto experiences and lessons learnt
  • The Fontan disease
  • Pregnancy and congenital heart disease
  • Pulmonary arterial hypertension
  • Tough end of life decisions and MAID
  • Guidelines session to tackle ongoing controversies and uncertainties

I expect the Symposium to provide the best of science and education in this area of practice. The Program is designed for all healthcare professionals working with Adult Congenital Heart Disease and should familiarize participants with the latest clinical information on the diagnosis and management for ACHD. Nurses and Cardiac Care Associates also have a major organizational and educational role within this Program.

Welcome to Toronto!

 

Erwin Oechslin, MD FRCPC
Director of the Symposium​

Quicklinks
Back to Top